Spots Global Cancer Trial Database for metastatic pheochromocytoma

Every month we try and update this database with for metastatic pheochromocytoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum	NCT00005860	Cancer	floxuridine leucovorin calc... oxaliplatin	18 Years -	National Cancer Institute (NCI)
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma	NCT00107289	Neuroblastoma Pheochromocytom...	iobenguane I 13...	1 Year -	Memorial Sloan Kettering Cancer Center
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors	NCT00002608	Adrenocortical ... Brain and Centr... Head and Neck C... Liver Cancer Malignant Mesot... Pheochromocytom... Sarcoma	cisplatin doxorubicin hyd... tamoxifen citra... conventional su... radiation thera...	- 65 Years	National Cancer Institute (NCI)
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
MIBG for Refractory Neuroblastoma and Pheochromocytoma	NCT01850888	Relapsed Neurob... Metastatic Pheo...	131 I-Metaiodob... Potassium iodid... G-CSF hematopoietic s...	1 Year -	Masonic Cancer Center, University of Minnesota
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma	NCT00107289	Neuroblastoma Pheochromocytom...	iobenguane I 13...	1 Year -	Memorial Sloan Kettering Cancer Center
131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma	NCT03649438	Relapsed Neurob... Metastatic Pheo...	131 I-Metaiodob... Potassium Iodid... G-csf	-	University of Texas Southwestern Medical Center
Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors	NCT00466856	Head and Neck C... Islet Cell Tumo... Metastatic Canc... Pheochromocytom...	octreotide acet... yttrium Y 90 re...	18 Years -	Vanderbilt-Ingram Cancer Center
131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma	NCT03649438	Relapsed Neurob... Metastatic Pheo...	131 I-Metaiodob... Potassium Iodid... G-csf	-	University of Texas Southwestern Medical Center
LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)	NCT03946527	Paraganglioma Pheochromocytom...	Lanreotide	18 Years -	Columbia University
131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma	NCT03649438	Relapsed Neurob... Metastatic Pheo...	131 I-Metaiodob... Potassium Iodid... G-csf	-	University of Texas Southwestern Medical Center
Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer	NCT00096083	Cancer	isolated perfus... melphalan	16 Years -	Delcath Systems Inc.

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: